期刊文献+

血小板添加剂的最新研究进展及其评估 被引量:2

Platelet additive solutions:a review of the latest developments and their evaluation
下载PDF
导出
摘要 输注血浆保存的血小板可能引起过敏、发热和循环超负荷等输血不良反应。因此,长期以来血液服务机构一直致力于血小板添加剂(PAS)的研究。如何通过优化血小板代谢和改变血小板储存温度来提高血小板体外保存的质和量是实验研究的热点。国外在这一领域的临床实践开展比较早,目前已经积累了大量临床资料和关于使用添加了PAS血液制品的经济效益分析。该研究就PAS如何解决这些问题的相关研究进展和国外的实践经验作一总结。 Transfusion of platelets with plasma may induce adverse transfusion reaction,like hypersusceptibility,fever and circulatory overload.Therefore,blood service always focuses on the research of platelet additive solution(PAS).The hotspots in this field include improving the metabolism of platelets and changing the temperature of platelet storage to advance the quality and quantity of the platelets in vitro.Foreign countries have done clinical practice in this field relatively early,and collected a large number of clinical outcomes and cost effectiveness on the use of PAS.The aim of this review is to summarize some recent researches on platelet storage issue and relevant experience in foreign countries.
作者 卿芸 毛伟 QING Yun;MAO Wei(Institution of Blood Transfusion,Chongqing Blood Center,Chongqing 400052,China)
出处 《国际检验医学杂志》 CAS 2022年第10期1260-1263,1278,共5页 International Journal of Laboratory Medicine
基金 重庆市九龙坡区科技计划项目(2019-02-019-Y)。
关键词 血小板添加剂 血小板 研究进展 platelet additive solutions platelet research progress
  • 相关文献

参考文献1

二级参考文献21

  • 1郭永,韩颖.回输的血小板在体内清除机制研究进展[J].中国实验血液学杂志,2006,14(5):1049-1052. 被引量:3
  • 2Diedrich B, Sandgren P, Jansson B, et al, In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang, 2008; 94:96 - 102.
  • 3Ringwald J, Ahhoff F, Zimmermann R, et al. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 hours of storage. Transfusion, 2006 ;46:236 - 243.
  • 4Cardigan R, Sutherland J, Garwood M, et al. In vitro function' of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang, 2008; 94:103- 112.
  • 5de-Wildt-Eggen J, Nauta S, Schrijver JG, et al. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion, 2000;40:398-403.
  • 6Kerkhoffs JL, Eikenboom JC, Schipperus MS, et al. A muhicenter randomised study of the efficacy of transfusions with platelets stored in PAS II versus plasma. Blood, 2006 ; 108:3210 - 3215.
  • 7van-Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the EuroSPRITE trial. Blood, 2003 ; 101:2426 - 2433.
  • 8McCullough J, Vesole DH, Benjamin R J, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood, 2004 ; 104 : 1534 - 1541.
  • 9van-Rhenen DJ. Clinical use of platelet additive solutions. Transfus Apher Sci, 2007 ; 37:269 - 272.
  • 10Keuren JF, Cauwenberghs S, Heeremans J, et al. Platelet ADP response deteriorates in synthetic storage media. Transfusion, 2006 ; 46:204 -212.

共引文献1

同被引文献6

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部